Form 4: Colgate-Palmolive Executive Tsourapas Exercises Stock Options and Sells Shares

Panagiotis Tsourapas, a Group President at Colgate-Palmolive, exercised stock options and sold shares on May 9, 2024.

Summary

• On May 9, 2024, Panagiotis Tsourapas, a Group President at Colgate-Palmolive, exercised stock options for 12,000 shares at a price of $72.29 per share.
• He then sold 12,000 shares at a weighted average price of $94.1545, with prices ranging from $94.15 to $94.1703.
• Following these transactions, Tsourapas directly owns 5,118 shares and indirectly owns 4,345 shares through the Issuer's 401(k) Plan Trustee and 69,204 shares through a trust.
• He also holds options to buy 54,794 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction appears to be a routine exercise of stock options and subsequent sale to cover costs.

Positives

• The exercise of stock options indicates confidence in the company's future performance.

Negatives

• The sale of shares could be interpreted as a lack of confidence, although it is likely related to covering the cost of exercising the options and associated taxes.

Industry Context

Executive stock option exercises and sales are common occurrences in publicly traded companies and are often related to compensation and personal financial planning.

Comparison to Industry Standards

• Executive compensation practices, including stock options, are generally benchmarked against peer companies within the consumer staples industry.
• Companies like Procter & Gamble (PG) and Unilever (UL) also utilize stock options as part of their executive compensation packages.
• The exercise and sale of shares by executives are typically disclosed via Form 4 filings, providing transparency to investors.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency into executive compensation and share ownership.

Key Dates